The latest oncology treatment & supportive care news
There’s still much to learn about how doxorubicin, a 50-year-old chemotherapy drug, causes its most…
Published in PNAS, a research team led by the University of Minnesota Medical School, USA, demonstrated…
University of Pittsburgh and UPMC Hillman Cancer Center researchers in the USA, have developed a…
The recent U.S. Food and Drug Administration approval of lifileucel, the first commercial tumour-infiltrating lymphocyte (TIL)…
Scientists have discovered a genetic aberration found in some prostate cancers that could allow more…
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center, USA, have uncovered new details about…
Two decades ago, Professor Michael Höckel, then Director of the Department of Gynaecology at Leipzig…
Researchers at University of California San Diego, USA, have found that the most common form…
In many cases of malignant melanoma, the effect of targeted treatment is lost over time.…
New clinical guidelines enabling a better understanding of childhood bone cancer will revolutionise treatment for…